Heifets L B, 1992, Am Rev Respir Dis, 145, 856, 10.1164/ajrccm/145.4_Pt_1.856
O'Brien R J, 1987, Rev Infect Dis, 9, 519, 10.1093/clinids/9.3.519
Heifets L B, 1985, Antimicrob Agents Chemother, 28, 570, 10.1128/AAC.28.4.570
Dautzenberg B, 1991, Am Rev Respir Dis, 144, 564, 10.1164/ajrccm/144.3_Pt_1.564
Hoy J, 1990, J Infect Dis, 161, 801, 10.1093/infdis/161.4.801
Iseman M D, 1988, Am Rev Respir Dis, 138, 767, 10.1164/ajrccm/138.4.767
Källenius G, 1989, Am Rev Respir Dis, 140, 264, 10.1164/ajrccm/140.1.264
Kent P T, 1985, Centers for Disease Control
Hoffner S E, 1990, J Clin Microbiol, 28, 1105, 10.1128/JCM.28.6.1105-1107.1990
Middlebrook G, 1977, Am Rev Respir Dis, 115, 1066
Hoffner S E, 1987, Eur J Clin Microbiol, 6, 530, 10.1007/BF02014241
Hoffner S E, 1989, J Antimicrob Chemother, 24, 317, 10.1093/jac/24.3.317
Heifets L B, 1991, Drug susceptibility in the chemotherapy of mycobacterial infections
Heifets L B, 1991, Drug susceptibility in the chemotherapy of mycobacterial infections
Heifets L B, 1988, Am Rev Respir Dis, 137, 711, 10.1164/ajrccm/137.3.711
Hoffner S E, 1989, Acta Leprolog, 7, 195
Yajko D M, 1988, Antimicrob Agents Chemother, 32, 1392, 10.1128/AAC.32.9.1392
Perrone C, 1990, Antimicrobial Agents Chemother, 34, 1508, 10.1128/AAC.34.8.1508
Mor N, 1993, Antimicrob Agents Chemother, 37, 111, 10.1128/AAC.37.1.111
Mor N, 1994, Pharmacotherapy, 14, 100, 10.1002/j.1875-9114.1994.tb02793.x
Wallace R J, 1995, J Infect Dis, 171, 747, 10.1093/infdis/171.3.747